Scarica l'app Stockscreener
4.94
9.52%
-0.52
Precedente Chiudi:
$5.46
Aprire:
$5.07
Volume 24 ore:
293.12K
Relative Volume:
0.78
Capitalizzazione di mercato:
$271.19M
Reddito:
$36.68M
Utile/perdita netta:
$-36.78M
Rapporto P/E:
-4.2586
EPS:
-1.16
Flusso di cassa netto:
$-26.75M
1 W Prestazione:
-9.19%
1M Prestazione:
-15.70%
6M Prestazione:
-2.37%
1 anno Prestazione:
+97.60%
Intervallo 1D:
$4.80
$5.24
Intervallo di 1 settimana:
$4.79
$5.77
Portata 52W:
$1.155
$10.37
Alpha Teknova Inc Stock (TKNO) Company Profile
Nome
Alpha Teknova Inc
Settore
Telefono
(831) 637-1100
Indirizzo
2451 BERT DRIVE, HOLLISTER
Confronta TKNO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TKNO
Alpha Teknova Inc
|
4.93 | 271.19M | 36.68M | -36.78M | -26.75M | -1.16 |
|
ZTS
Zoetis Inc
|
161.36 | 73.88B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.20 | 48.17B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.48 | 47.59B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.07 | 17.28B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.41 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Alpha Teknova Inc Stock (TKNO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Iniziato | Craig Hallum | Buy |
| 2024-03-12 | Downgrade | BTIG Research | Buy → Neutral |
Alpha Teknova Inc Borsa (TKNO) Ultime notizie
(TKNO) On The My Stocks Page - news.stocktradersdaily.com
Teknova And Pluristyx Launch PluriFreeze Cryopreservation System To Streamline Cell Therapy - Nasdaq
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies - The Manila Times
Revolutionary Cell Therapy Preservation: Teknova's New PluriFreeze System Transforms Development Process - StockTitan
How the (TKNO) price action is used to our Advantage - news.stocktradersdaily.com
Alpha Teknova, Inc. (NASDAQ:TKNO) Sees Large Increase in Short Interest - Defense World
Sector Update: Health Care Stocks Decline Wednesday Afternoon - TradingView
Sector Update: Health Care -March 12, 2025 at 08:46 am EDT - Marketscreener.com
Alpha Teknova, Pluristyx Partner to Produce, Distribute PluriFreeze for Cell Therapies -March 12, 2025 at 04:23 am EDT - Marketscreener.com
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies - The Manila Times
Alpha Teknova and Pluristyx Announce Collaboration to Commercialize PluriFreeze Cryopreservation System for Cell Therapies - Nasdaq
Teknova, Pluristyx announce collaboration over next-generation cell therapies - TipRanks
Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.67 - Yahoo Finance
Alpha Teknova, Inc. SEC 10-K Report - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets - Simply Wall St
Alpha Teknova’s Earnings Call: Growth Amid Challenges - TipRanks
Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2024 Earnings Call Transcript - MSN
Positive Outlook for Alpha Teknova: Strong Financial Performance and Growth Potential - TipRanks
Alpha Teknova stock holds as KeyBanc maintains rating By Investing.com - Investing.com South Africa
Alpha Teknova stock holds as KeyBanc maintains rating - Investing.com India
Alpha Teknova: Strong Revenue Growth and Strategic Positioning Justify Buy Rating - TipRanks
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Alpha Teknova: Q4 Earnings Snapshot - Midland Daily News
Alpha Teknova Reports Steady Revenue Growth in 2024 - TipRanks
Earnings call transcript: Alpha Teknova Q4 2024 shows revenue growth, stock edges up - Investing.com India
Alpha Teknova: Q4 Earnings Snapshot -March 04, 2025 at 05:12 pm EST - Marketscreener.com
Alpha Teknova, Inc. Q4 Loss Narrows - Nasdaq
Alpha Teknova, Inc. Reports 3% Revenue Growth for 2024 and Provides 2025 Guidance of $39-42 Million - Nasdaq
Can Teknova's 110% Clinical Solutions Growth Offset Continued Losses? - StockTitan
Stock Index Futures Mixed as Investors Weigh Trump Tariffs - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 54.3% in February - Defense World
Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO) - Simply Wall St
When the Price of (TKNO) Talks, People Listen - Stock Traders Daily
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - The Manila Times
Alpha Teknova, Inc. Scheduled to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Nasdaq
Q4 Earnings: Can Teknova's Critical Reagents Business Show Growth Momentum? - StockTitan
Nkcfo LLC Makes New Investment in Alpha Teknova, Inc. (NASDAQ:TKNO) - MarketBeat
Leading Driver In The Ready-To-Use Luria-Bertani LB Liquid Medium Market 2025: Surge In R&D Activities Driving - EIN News
Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World
Alpha Teknova (NASDAQ:TKNO) Shares Gap UpTime to Buy? - MarketBeat
Alpha Teknova (NASDAQ:TKNO) Earns Buy Rating from Analysts at Craig Hallum - MarketBeat
(TKNO) Technical Data - Stock Traders Daily
Here’s What Boosted Alpha Teknova (TKNO) in Q4 - Yahoo Finance
Craig-Hallum initiates Alpha Teknova stock with buy rating - MSN
Alpha Teknova Inc Azioni (TKNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
7.85%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):